Clinical Applications of Cost Analysis of Diabetic Macular Edema Treatments (vol 119, pg 2558, 2012)

被引：0
|
作者：
Smiddy, William E.
机构：
来源：
OPHTHALMOLOGY | 2013年 / 120卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
引用
收藏
页码：676 / 676
页数：1
相关论文
共 50 条
  • [31] Cost-effectiveness analysis of bispecific antibody faricimab for treatment of neovascular age-related macular degeneration and diabetic macular edema in Japan
    Yanagi, Yasuo
    Tsujimura, Jun
    Ohno, Shinya
    Higashi, Kentaro
    Sakashita, Naotaka
    Shoji, Ayako
    Igarashi, Ataru
    JOURNAL OF MEDICAL ECONOMICS, 2025, 28 (01) : 448 - 459
  • [32] RETRACTION: Effect of 3-Hour Normobaric Hyperoxia on Diabetic Macular Edema (Retraction of Vol 60, Pg 2635, 2019)
    Minturn, Robert
    Seto, Brendan
    Yamada, Keiko
    Zeng, Ke
    Arroyo, Jorge G.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2022, 63 (03)
  • [33] Clinical applications of the SAVE grading protocol for diabetic macular edema based on optical coherence tomography and fluorescein angiography criteria
    Vetrivel, Vignesh
    Sim, Dawn A.
    Keane, Pearse Andrew
    Van Velthoven, Mirjam E. J.
    Zarranz-Ventura, Javier
    Heussen, Florian M.
    Bolz, Matthias
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2014, 55 (13)
  • [34] Cost-effectiveness of bevacizumab versus ranibizumab in patients with diabetic macular edema. Analysis from the BRDME study
    Vader, M. J. C.
    Verbraak, F. D.
    Dijkman, G.
    Hooymans, J. M. M.
    Los, L. I.
    Peto, T.
    Hoyng, C. B.
    van Leeuwen, R.
    Vingerling, J. R.
    Moll, A. C.
    van Lith-Verhoeven, J. J. C.
    Schlingemann, R. O.
    Dijkgraaf, M. G. W.
    ACTA OPHTHALMOLOGICA, 2020, 98 : 42 - 42
  • [35] COST EFFECTIVENES ANALYSIS OF RANIBIZUMAB COMPARED TO AFLIBERCEPT AND LASER INTERVENTION IN TREATMENT OF DIABETIC MACULAR EDEMA (DME) IN THE CZECH REPUBLIC
    Klimes, J.
    Regnier, S. A.
    Mahon, R.
    Budek, T.
    Dostal, F.
    Skalicky, D.
    Depta, J.
    VALUE IN HEALTH, 2015, 18 (07) : A419 - A419
  • [36] Cost-consequence analysis of extended loading dose of anti-VEGF treatment in diabetic macular edema patients
    Ruiz-Moreno, J. M.
    de Andres-Nogales, F.
    Oyagueez, I.
    BMC OPHTHALMOLOGY, 2020, 20 (01)
  • [37] Cost-consequence analysis of extended loading dose of anti-VEGF treatment in diabetic macular edema patients
    J. M. Ruiz-Moreno
    F. de Andrés-Nogales
    I. Oyagüez
    BMC Ophthalmology, 20
  • [38] EXTENDED LOADING DOSE OF ANTI-VEGF TREATMENT IN DIABETIC MACULAR EDEMA PATIENTS: A COST-CONSEQUENCE ANALYSIS
    de Andres-Nogales, F.
    Ruiz-Moreno, J. M.
    Oyaguez, I
    Casado, M. A.
    VALUE IN HEALTH, 2019, 22 : S887 - S887
  • [39] Association of Abnormal Renal Profiles and Proliferative Diabetic Retinopathy and Diabetic Macular Edema in an Asian Population With Type 2 Diabetes (vol 136, pg 68, 2018)
    Hsieh, Y-T
    Tsai, M-J
    Tu, S-T
    Hsieh, M-C
    JAMA OPHTHALMOLOGY, 2019, 137 (02) : 233 - 233
  • [40] Iluvien™ (Fluocinolone Acetonide 0.19 mg Intravitreal Implant) in the Treatment of Diabetic Macular Edema: A Review (vol 7, pg 293, 2018)
    Fusi-Rubiano, William
    Blow, Rebecca R.
    Lane, Mark
    Morjaria, Rupal
    Denniston, Alastair K.
    OPHTHALMOLOGY AND THERAPY, 2020, 9 (01) : 205 - 205
12345